These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1792471)

  • 21. Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
    Thase ME
    J Clin Psychiatry; 2006 Apr; 67(4):671-2. PubMed ID: 16669733
    [No Abstract]   [Full Text] [Related]  

  • 22. The relationship of acetylation phenotype to treatment with MAOIs: a review.
    Rose S
    J Clin Psychopharmacol; 1982 Jun; 2(3):161-4. PubMed ID: 7096607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of the cardiac-impaired depressed patient. Part I: General considerations, heterocyclic antidepressants, and monoamine oxidase inhibitors.
    Goldstein MG; Guttmacher LB
    Psychiatr Med; 1988; 6(3):1-33. PubMed ID: 3062672
    [No Abstract]   [Full Text] [Related]  

  • 24. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.
    Müller DJ; Schulze TG; Macciardi F; Ohlraun S; Gross MM; Scherk H; Neidt H; Syagailo YV; Grässle M; Nöthen MM; Maier W; Lesch KP; Rietschel M
    Pharmacopsychiatry; 2002 Jul; 35(4):157-8. PubMed ID: 12163988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 26. [Special aspects of antidepressive therapy].
    Nervenarzt; 1994 Mar; 65(3 Suppl [speziell]):1-8. PubMed ID: 9218059
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin agonists and beta-adrenergic agonists as a treatment for depressive disorder: a direct clinical application.
    Stahl SM
    Psychopharmacol Bull; 1985; 21(1):43-7. PubMed ID: 2984713
    [No Abstract]   [Full Text] [Related]  

  • 28. Depression: advances in drug treatment.
    Hopkins S
    Nurs Stand; 1993 Nov 24-30; 8(10):36. PubMed ID: 8297750
    [No Abstract]   [Full Text] [Related]  

  • 29. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tricyclics, MAOI and electroshock therapy in the treatment of depressive syndromes].
    Carolei A; Frontoni M
    Clin Ter; 1981 Jul; 98(1):75-86. PubMed ID: 7018824
    [No Abstract]   [Full Text] [Related]  

  • 31. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics.
    Fangmann P; Assion HJ; Juckel G; González CA; López-Muñoz F
    J Clin Psychopharmacol; 2008 Feb; 28(1):1-4. PubMed ID: 18204333
    [No Abstract]   [Full Text] [Related]  

  • 32. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine oxidase inhibitors--current status.
    Zemishlany Z; Radwan M; Wijsenbeek H
    Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
    [No Abstract]   [Full Text] [Related]  

  • 34. The Australian multicentre moclobemide trial.
    Stanton J
    Aust N Z J Psychiatry; 1993 Mar; 27(1):158. PubMed ID: 8481158
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacology of reversible monoamine oxidase inhibitors.
    Amrein R; Allen SR; Guentert TW; Hartmann D; Lorscheid T; Schoerlin MP; Vranesic D
    Br J Psychiatry Suppl; 1989 Oct; (6):66-71. PubMed ID: 2695128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAOI-carbamazepine combination and statistical power.
    Blanco-Jerez C; Robles DE; Gilaberte-Asin I; Blanco C
    J Clin Psychiatry; 1996 Jul; 57(7):311-2. PubMed ID: 8666579
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of depression: update 1984.
    Enowitch BI
    Conn Med; 1984 Nov; 48(11):703-6. PubMed ID: 6391806
    [No Abstract]   [Full Text] [Related]  

  • 38. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On combining TCAs and MAOIs.
    Grounds D
    Aust N Z J Psychiatry; 1993 Jun; 27(2):344, 346. PubMed ID: 8363548
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined MAOI-tricylic antidepressant treatment: a controlled trial.
    White K; Razani J; Simpson G; Rebal R; Sloane RB; O'Leary J; Palmer R
    Psychopharmacol Bull; 1982 Oct; 18(4):180-1. PubMed ID: 6760234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.